Literature DB >> 17973643

Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects.

B Kuo1, R W McCallum, K L Koch, M D Sitrin, J M Wo, W D Chey, W L Hasler, J M Lackner, L A Katz, J R Semler, G E Wilding, H P Parkman.   

Abstract

BACKGROUND: Gastric emptying scintigraphy (GES) using a radio-labelled meal is used to measure gastric emptying. A nondigestible capsule, SmartPill, records luminal pH, temperature, and pressure during gastrointestinal transit providing a measure of gastric emptying time (GET). AIMS: To compare gastric emptying time and GES by assessing their correlation, and to compare GET and GES for discriminating healthy subjects from gastroparetics.
METHODS: Eighty-seven healthy subjects and 61 gastroparetics enrolled with simultaneous SmartPill and GES. Fasted subjects were ingested capsule and [(99m)Tc]-SC radio-labelled meal. Images were obtained every 30 min for 6 h. Gastric emptying time and percentage of meal remaining at 2/4 h were determined for each subject. The sensitivity/specificity and receiver operating characteristic analysis of each measure were determined for each subject.
RESULTS: Correlation between GET and GES-4 h was 0.73 and GES-2 h was 0.63. The diagnostic accuracy from the receiver operating characteristic curve between gastroparetics and healthy subjects was GET = 0.83, GES-4 h = 0.82 and GES-2 h = 0.79. The 300-min cut-off time for GET gives sensitivity of 0.65 and specificity of 0.87 for diagnosis of gastroparesis. The corresponding sensitivity/specificity for 2 and 4 h standard GES measures were 0.34/0.93 and 0.44/0.93, respectively.
CONCLUSION: SmartPill GET correlates with GES and discriminates between healthy and gastroparetic subjects offering a nonradioactive, standardized, ambulatory alternative to scintigraphy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17973643     DOI: 10.1111/j.1365-2036.2007.03564.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  94 in total

1.  Clinical utility of wireless motility capsule in patients with suspected multiregional gastrointestinal dysmotility.

Authors:  Zubin Arora; Jose Mari Parungao; Rocio Lopez; Cynthia Heinlein; Janice Santisi; Sigurbjorn Birgisson
Journal:  Dig Dis Sci       Date:  2014-11-16       Impact factor: 3.199

Review 2.  Methods for the assessment of small-bowel and colonic transit.

Authors:  Lawrence A Szarka; Michael Camilleri
Journal:  Semin Nucl Med       Date:  2012-03       Impact factor: 4.446

3.  A technical review and clinical assessment of the wireless motility capsule.

Authors:  Richard J Saad; William L Hasler
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-12

4.  Impact of acid suppression on upper gastrointestinal pH and motility.

Authors:  Whitney Michalek; John R Semler; Braden Kuo
Journal:  Dig Dis Sci       Date:  2010-11-18       Impact factor: 3.199

Review 5.  Biomagnetic methods: technologies applied to pharmaceutical research.

Authors:  Luciana A Corá; Madileine F Américo; Ricardo B Oliveira; Cristina H R Serra; Oswaldo Baffa; Raul C Evangelista; Giselle F Oliveira; José Ricardo Aruda Miranda
Journal:  Pharm Res       Date:  2010-10-15       Impact factor: 4.200

6.  Evaluation of regional and whole gut motility using the wireless motility capsule: relevance in clinical practice.

Authors:  Khoa Tran; Rita Brun; Braden Kuo
Journal:  Therap Adv Gastroenterol       Date:  2012-07       Impact factor: 4.409

Review 7.  Wireless endoscopy in 2020: Will it still be a capsule?

Authors:  Anastasios Koulaouzidis; Dimitris K Iakovidis; Alexandros Karargyris; Emanuele Rondonotti
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

Review 8.  Gastroparesis: what is the current state-of-the-art for evaluation and medical management? What are the results?

Authors:  Allen Lee
Journal:  J Gastrointest Surg       Date:  2013-06-26       Impact factor: 3.452

9.  Intestinal pH and gastrointestinal transit profiles in cystic fibrosis patients measured by wireless motility capsule.

Authors:  Daniel Gelfond; Changxing Ma; Jack Semler; Drucy Borowitz
Journal:  Dig Dis Sci       Date:  2012-05-17       Impact factor: 3.199

Review 10.  Gastroparesis: Medical and Therapeutic Advances.

Authors:  Christopher M Navas; Nihal K Patel; Brian E Lacy
Journal:  Dig Dis Sci       Date:  2017-07-18       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.